Amneal Pharmaceuticals, Inc. (AMRX)

21.38 USD-1.47%close 2026-11-13Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$7.45B52 Week Range: 11.52 – 21.7
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.52.15EPS 0.41
The live quote provider is unreachable; the last known close is shown.

Amneal Pharmaceuticals, Inc. (AMRX) is not among the 30 most-held stocks of the tracked superinvestor set. Price 21.38 USD; market cap $7.45B.

Price & valuation

Prev Close21.7
Open—
Day Range—
52 Week Range11.52 – 21.7
Volume—
Avg Volume (3M)—
Market Cap$7.45BSEC 10-Q, 10/30/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.772 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.52.15SEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.0.41SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own AMRX?

Amneal Pharmaceuticals, Inc. (AMRX) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on AMRX bullish or bearish?

AMRX is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.